Top Suppliers:I want be here

1427004-19-0

1427004-19-0 structure
1427004-19-0 structure
  • Name: DBCO-PEG4-NHS ester
  • Chemical Name: 4-(11,12-Didehydrodibenzo[b,f]azocin-5(6H)-yl)-N-{15-[(2,5-dioxo-1-pyrrolidinyl)oxy]-15-oxo-3,6,9,12-tetraoxapentadec-1-yl}-4-oxobutanamide
  • CAS Number: 1427004-19-0
  • Molecular Formula: C34H39N3O10
  • Molecular Weight: 649.688
  • Catalog: Signaling Pathways PROTAC PROTAC Linker
  • Create Date: 2018-06-07 11:14:07
  • Modify Date: 2024-01-09 09:06:18
  • DBCO-PEG4-NHS ester is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1].

Name 4-(11,12-Didehydrodibenzo[b,f]azocin-5(6H)-yl)-N-{15-[(2,5-dioxo-1-pyrrolidinyl)oxy]-15-oxo-3,6,9,12-tetraoxapentadec-1-yl}-4-oxobutanamide
Synonyms Dibenz[b,f]azocine-5(6H)-butanamide, 11,12-didehydro-N-[15-[(2,5-dioxo-1-pyrrolidinyl)oxy]-15-oxo-3,6,9,12-tetraoxapentadec-1-yl]-γ-oxo-
4-(11,12-Didehydrodibenzo[b,f]azocin-5(6H)-yl)-N-{15-[(2,5-dioxo-1-pyrrolidinyl)oxy]-15-oxo-3,6,9,12-tetraoxapentadec-1-yl}-4-oxobutanamide
Description DBCO-PEG4-NHS ester is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1].
Related Catalog
Target

PEGs

In Vitro PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1].
References

[1]. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562

Density 1.3±0.1 g/cm3
Molecular Formula C34H39N3O10
Molecular Weight 649.688
Exact Mass 649.263550
LogP 0.56
Index of Refraction 1.608
Storage condition -20°C